Bando Chemical Industries, Ltd. (TYO:5195)
Japan · Delayed Price · Currency is JPY 2,318.00
-24.00 (-1.02%)
Feb 13, 2026, 3:30 PM JST
Bando Chemical Industries Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 117,509 | 115,593 | 108,278 | 103,608 | 93,744 | 81,371 | |
Revenue Growth (YoY) | 2.31% | 6.76% | 4.51% | 10.52% | 15.21% | -9.84% |
Cost of Revenue | 82,678 | 82,805 | 77,246 | 74,186 | 66,081 | 56,520 |
Gross Profit | 34,831 | 32,788 | 31,032 | 29,422 | 27,663 | 24,851 |
Selling, General & Admin | 25,673 | 25,044 | 23,447 | 22,687 | 21,782 | 19,912 |
Other Operating Expenses | -2,419 | 120 | -113 | -127 | -110 | -70 |
Operating Expenses | 23,254 | 25,164 | 23,334 | 22,560 | 21,672 | 19,842 |
Operating Income | 11,577 | 7,624 | 7,698 | 6,862 | 5,991 | 5,009 |
Interest Expense | -630 | -94 | -89 | -84 | -120 | -136 |
Interest & Investment Income | 701 | 556 | 422 | 327 | 291 | 293 |
Earnings From Equity Investments | 1,274 | 1,629 | 1,468 | 1,448 | 1,025 | 520 |
Currency Exchange Gain (Loss) | - | -285 | 827 | 305 | 550 | 76 |
Other Non Operating Income (Expenses) | -3 | 274 | -218 | -227 | 61 | 42 |
EBT Excluding Unusual Items | 12,919 | 9,704 | 10,108 | 8,631 | 7,798 | 5,804 |
Merger & Restructuring Charges | - | -1,117 | - | - | - | - |
Gain (Loss) on Sale of Assets | - | -25 | -6 | -76 | -58 | -81 |
Asset Writedown | -2,531 | -5,091 | -1,427 | -14 | -4,327 | -105 |
Pretax Income | 6,982 | 3,471 | 8,675 | 8,541 | 3,413 | 5,618 |
Income Tax Expense | 2,547 | 1,931 | 2,458 | 2,780 | 2,197 | 1,660 |
Earnings From Continuing Operations | 4,435 | 1,540 | 6,217 | 5,761 | 1,216 | 3,958 |
Minority Interest in Earnings | -25 | -44 | -37 | -39 | -5 | -15 |
Net Income | 4,410 | 1,496 | 6,180 | 5,722 | 1,211 | 3,943 |
Net Income to Common | 4,410 | 1,496 | 6,180 | 5,722 | 1,211 | 3,943 |
Net Income Growth | -18.79% | -75.79% | 8.00% | 372.50% | -69.29% | 478.15% |
Shares Outstanding (Basic) | 41 | 42 | 43 | 44 | 45 | 46 |
Shares Outstanding (Diluted) | 41 | 42 | 43 | 44 | 45 | 46 |
Shares Change (YoY) | -2.74% | -2.27% | -1.53% | -2.16% | -1.22% | -0.39% |
EPS (Basic) | 106.31 | 35.31 | 142.55 | 129.96 | 26.91 | 86.56 |
EPS (Diluted) | 106.31 | 35.31 | 142.55 | 129.96 | 26.91 | 86.56 |
EPS Growth | -16.50% | -75.23% | 9.68% | 382.92% | -68.91% | 480.42% |
Free Cash Flow | 10,013 | 6,497 | 9,940 | 4,188 | 6,124 | 6,632 |
Free Cash Flow Per Share | 241.37 | 153.33 | 229.28 | 95.12 | 136.09 | 145.59 |
Dividend Per Share | 78.000 | 76.000 | 72.000 | 52.000 | 40.000 | 26.000 |
Dividend Growth | 2.63% | 5.56% | 38.46% | 30.00% | 53.85% | -18.75% |
Gross Margin | 29.64% | 28.37% | 28.66% | 28.40% | 29.51% | 30.54% |
Operating Margin | 9.85% | 6.60% | 7.11% | 6.62% | 6.39% | 6.16% |
Profit Margin | 3.75% | 1.29% | 5.71% | 5.52% | 1.29% | 4.85% |
Free Cash Flow Margin | 8.52% | 5.62% | 9.18% | 4.04% | 6.53% | 8.15% |
EBITDA | 16,989 | 13,442 | 13,557 | 12,756 | 11,883 | 10,982 |
EBITDA Margin | 14.46% | 11.63% | 12.52% | 12.31% | 12.68% | 13.50% |
D&A For EBITDA | 5,412 | 5,818 | 5,859 | 5,894 | 5,892 | 5,973 |
EBIT | 11,577 | 7,624 | 7,698 | 6,862 | 5,991 | 5,009 |
EBIT Margin | 9.85% | 6.60% | 7.11% | 6.62% | 6.39% | 6.16% |
Effective Tax Rate | 36.48% | 55.63% | 28.33% | 32.55% | 64.37% | 29.55% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.